QuikReader

QuikReader

  • Latest
  • Top stories
  • Business
  • Tech
  • World
  • Politics
  • Sports
  • Lifestyle
  • Health
  • Science
  • Entertainment
  • More
    • Sources
Sign in

Latest in Weight Loss Drug Will Be Offered for $499 a Month for Some Patients

Sort by
454 items

  • Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

    Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.
    CNBC - Feb. 24
  • Novo’s Weight Loss Drugs Removed from FDA Shortage List

    Novo’s Weight Loss Drugs Removed from FDA Shortage List

    The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list.
    Inc. - Feb. 22

  • Healthy Returns: AbbVie is the newest potential weight loss drug market player

    AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra's obesity drug. AI takes center stage at HIMSS conference gets underway in Vegas.
    CNBC - 1d
  • Drug compounders sue over weight loss drugs' removal from FDA shortage list

    Drug compounders sue over weight loss drugs' removal from FDA shortage list

    A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...
    The Hill - Feb. 25

  • From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

    Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
    CNBC - Feb. 20

  • Why Walmart’s warning may have more to do with weight-loss drugs than tariffs

    Walmart’s stock fell Thursday as quarterly earnings were expected to decline for the first time in three years, with strength in groceries and GLP-1 drug sales continuing to pressure margins.
    MarketWatch - Feb. 21
  • We know so little about taking weight-loss drugs without prescription – is it really worth it? | Devi Sridhar

    We know so little about taking weight-loss drugs without prescription – is it really worth it? | Devi Sridhar

    Studies show that they’re effective for overweight people, but if you’re healthy, there are less risky ways to lose weight. When I’ve been in the gym over the past few months, one of the things ...
    The Guardian - Feb. 25

  • Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

    Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.
    CNBC - Feb. 25

  • Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

    The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.
    MarketWatch - Feb. 26

  • There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers

    Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.
    MarketWatch - 22h

  • Amgen starts two critical late-stage trials for weight loss drug MariTide

    MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.
    CNBC - 20h
  • Cancer patients 'may starve' without vital drug

    Cancer patients 'may starve' without vital drug

    Creon, a pancreatic enzyme replacement therapy, helps digestion but stocks are desperately low.
    BBC News - 6d
  • Florida Seeks Drug Prescription Data With Names of Patients and Doctors

    Florida Seeks Drug Prescription Data With Names of Patients and Doctors

    The state’s insurance regulator has demanded detailed information about patients and their medications, raising privacy concerns.
    The New York Times - 17h
  • MS patients suffer side-effects after NHS England switches to cheaper drug

    MS patients suffer side-effects after NHS England switches to cheaper drug

    Scores of people experience complications after change from Tysabri to Tyruko as part of NHS drive to save money. ‘It was awful for me’: one MS patient shares her experience with Tyruko Scores ...
    The Guardian - Feb. 24

  • Hims & Hers shares plunge 22% on concerns over weight loss business, margins

    Hims & Hers on Monday released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.
    CNBC - Feb. 25

  • Trump offers one-month tariff exemption to U.S. automakers

    Automakers will get a one-month reprieve from 25% tariffs on imports from Mexico and Canada.
    CBS News - 15h
  • Why Demi Moore’s Oscar Loss to Mikey Madison Stings for Some Fans

    Why Demi Moore’s Oscar Loss to Mikey Madison Stings for Some Fans

    Moore had been considered a favorite for her strong performance in “The Substance,” but Madison won for “Anora.”
    The New York Times - 2d
  • Doctor on trial for abusing hundreds of patients in France confesses

    Doctor on trial for abusing hundreds of patients in France confesses

    Yahoo News - Feb. 24
  • GPs accused of leaving bills unpaid and patients in danger

    GPs accused of leaving bills unpaid and patients in danger

    GP firm says it is "committed to delivering the highest standards of care" in wake of criticism.
    BBC News - Feb. 26

  • What possible compounded semaglutide ban means for patients

    The FDA declared the shortage of Novo Nordisk's weight-loss drugs over, giving compounders until May to stop making alternatives. An industry group representing compounders is suing. Dr. Angela ...
    CBS News - 6d
  • Frail patients 'told to soil themselves' at A&E

    Frail patients 'told to soil themselves' at A&E

    The Medway Maritime Hospital is rated as "requires improvement" by the Care Quality Commission.
    BBC News - 1d
  • An Overdiagnosis Epidemic Is Harming Patients’ Mental Health

    An Overdiagnosis Epidemic Is Harming Patients’ Mental Health

    Diagnosing patients when there aren’t effective treatments to give them can make their symptoms worse, argues neurologist Suzanne O’Sullivan.
    Wired - 19h
  • Ozempic: $1,400/Month—Compounded Version: $250/Month

    Ozempic: $1,400/Month—Compounded Version: $250/Month

    The real cost? Your medical license.
    Inc. - Feb. 19

  • How February revealed the toughness of the UFC's 'easiest' weight class

    Fans and pundits hearken back to the days of Anderson Silva, but 185 pounds may be at its best right now.
    ESPN - 5d
  • One Month into the Trump Presidency

    One Month into the Trump Presidency

    The president has moved swiftly to remake Washington. But for business leaders, that volatility has often been hard to navigate.
    The New York Times - Feb. 21
  • It’s Jekyll and Hyde, says son of French surgeon accused of abusing 299 patients

    It’s Jekyll and Hyde, says son of French surgeon accused of abusing 299 patients

    Relatives of Joël Le Scouarnec, who allegedly sexually assaulted young patients, tell court of split personality. Members of a French surgeon’s family have described discovering the “Jekyll and ...
    The Guardian - Feb. 26
  • Bukavu hospital patients tell of being shot in chaos of Congolese withdrawal

    Bukavu hospital patients tell of being shot in chaos of Congolese withdrawal

    Widespread shooting and looting preceded arrival of M23 rebels, overwhelming city’s poorly resourced facilities. Patients at hospitals in the second-largest city in eastern Democratic Republic of ...
    The Guardian - 4d
  • Rebels in eastern Congo abducted 130 hospital patients, UN says

    Rebels in eastern Congo abducted 130 hospital patients, UN says

    Yahoo News - 2d
  • Second nurse charged over video threatening Israeli patients

    Second nurse charged over video threatening Israeli patients

    Australian police have been investigating the video, which circulated widely online and caused public outcry.
    BBC News - 1d

  • Map shows drug overdose death trends by state

    Data shows overdose deaths decreased by 4% between 2022 and 2023. The trend continued into 2024.
    CBS News - Feb. 21
  • Trump’s FDA Cuts Are Putting Drug Development at Risk

    Trump’s FDA Cuts Are Putting Drug Development at Risk

    New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.
    Wired - 2d

  • Vance blasts Canada on drug trade as tariffs begin

    Vice President JD Vance is calling out Canada, suggesting the U.S. ally needs to do more to prevent drugs from entering the country through its border. CBS News' Olivia Rinaldi reports on the ...
    CBS News - 1d

  • Donald Trump’s first month in charts

    The US president has hit the ground running, but he is dogged by stubborn inflation and tepid approval ratings
    Financial Times - Feb. 21
  • Muslims begin holy month of Ramadan

    Muslims begin holy month of Ramadan

    Ramadan starts with sighting the crescent moon and most mosques observing the first day on Saturday.
    BBC News - 5d
  • Cohere’s first vision model Aya Vision is here with broad, multilingual understanding and open weights — but there’s a catch

    Cohere’s first vision model Aya Vision is here with broad, multilingual understanding and open weights — but there’s a catch

    Aya Vision 8B and 32B demonstrate best-in-class performance relative to their parameter size, outperforming much larger models.
    VentureBeat - 1d
  • Some Schools Rethink “College For All”

    Some Schools Rethink “College For All”

    The idea that every student should aim for a four-year college motivated a bipartisan movement for decades. Now even enthusiastic promoters of the idea are reconsidering it.
    The New York Times - 2h
  • Delta Offers $30,000 to Passengers on Plane That Crashed in Toronto

    Delta Offers $30,000 to Passengers on Plane That Crashed in Toronto

    The airline said it told the 76 passengers who had been on the plane, which crashed and flipped over on Monday, that the offer came with “no strings attached.”
    The New York Times - Feb. 20
  • Christie offers hilarious reaction to Murray's engagement

    Christie offers hilarious reaction to Murray's engagement

    Sacramento Kings interim coach Doug Christie gave a funny reaction to forward Keegan Murray's engagement to longtime girlfriend over All-Star Weekend.
    Yahoo Sports - Feb. 21
  • The Papers: 'Zelensky offers to quit' and 'Germany turns Right'

    The Papers: 'Zelensky offers to quit' and 'Germany turns Right'

    Volodymyr Zelensky's offer to step down as president of Ukraine features heavily in Monday's papers.
    BBC News - Feb. 24

  • Macron, Trump offer contrasting paths to peace in Ukraine

    French President Emmanuel Macron met with President Trump at the White House on Monday, marking three years since Russia invaded Ukraine. The meeting came after European powers were excluded from ...
    CBS News - Feb. 24
  • 1
  • 2
  • 3
  • »
  Follow topic
Topics
  • Weight Loss Drug
  • Loss Drug Be
  • Drug Be Offered
  • Be Offered Month
  • Offered Month Patients
© 2025 QuikReader - About - Terms - Privacy